Detalles de la búsqueda
1.
Subcutaneous versus Intravenous Amivantamab, both in Combination with Lazertinib, in Refractory EGFR-mutated NSCLC: Primary Results from the Phase 3 PALOMA-3 Study.
J Clin Oncol;
: JCO2401001, 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38857463
2.
Locally Advanced Relapse May Not Be Equal to Stage 3 Non-Small Cell Lung Cancer.
JAMA Oncol;
10(6): 828-829, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38573631
3.
Neoadjuvant nivolumab plus chemotherapy followed by resection for superior sulcus tumour with high PD-L1 expression: A case report.
Respirol Case Rep;
12(5): e01358, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38680669
4.
Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin-based chemotherapy using short hydration: A randomized phase II trial.
Cancer Med;
13(4): e6839, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38457231
5.
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.
Nat Commun;
15(1): 2287, 2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38480701
6.
Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer.
J Immunother Cancer;
12(2)2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38360040
7.
NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study.
Mol Oncol;
18(2): 305-316, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37864465
8.
A Phase II Study of High-Flow Nasal Cannula for Relieving Dyspnea in Advanced Cancer Patients.
J Pain Symptom Manage;
67(3): 204-211.e1, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37992848
9.
Adjacent angle size correlates with diagnostic sensitivity of endobronchial ultrasonography with a guide sheath.
J Thorac Dis;
15(11): 6019-6028, 2023 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38090301
10.
Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.
JAMA Netw Open;
6(12): e2347700, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38100106
11.
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
N Engl J Med;
389(18): 1672-1684, 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37870974
12.
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.
N Engl J Med;
389(22): 2063-2075, 2023 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37861218
13.
Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: treatment rationale and protocol design of the B-DASH study (WJOG 14720 L).
BMC Cancer;
23(1): 902, 2023 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37749521
14.
First-line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non-squamous non-small cell lung cancer: Updated survival analysis of the ONO-4538-52/TASUKI-52 randomized controlled trial.
Cancer Med;
12(16): 17061-17067, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37641544
15.
Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.
Res Sq;
2023 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37502925
16.
Acquired Secondary HER2 Mutations Enhance HER2/MAPK Signaling and Promote Resistance to HER2 Kinase Inhibition in Breast Cancer.
Cancer Res;
83(18): 3145-3158, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37404061
17.
Study Design and Rationale for Marble Study: A Phase II Trial of Atezolizumab (MPDL3280A) Plus Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Thymic Carcinoma (JTD2101).
Clin Lung Cancer;
24(7): e247-e253, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37316381
18.
Carboplatin and irinotecan (CI) vs. carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial.
Lung Cancer;
181: 107195, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37156212
19.
Effectiveness and Safety of Atezolizumab Monotherapy in Previously Treated Japanese Patients With Unresectable Advanced or Recurrent NSCLC: A Multicenter, Prospective, Observational Study (J-TAIL).
JTO Clin Res Rep;
4(3): 100484, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37034464
20.
Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility.
JAMA Netw Open;
6(2): e230698, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36826813